CoraLite®594-conjugated ITM2C Monoclonal antibody
ITM2C Monoclonal Antibody for IF/ICC
Host / Isotype
Mouse / IgG2a
Reactivity
human, canine
Applications
IF/ICC
Conjugate
CoraLite®594 Fluorescent Dye
CloneNo.
2E8G11
Cat no : CL594-60095
Synonyms
Validation Data Gallery
Tested Applications
Positive IF/ICC detected in | HepG2 cells, MDCK cells |
Recommended dilution
Application | Dilution |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
CL594-60095 targets ITM2C in IF/ICC applications and shows reactivity with human, canine samples.
Tested Reactivity | human, canine |
Host / Isotype | Mouse / IgG2a |
Class | Monoclonal |
Type | Antibody |
Immunogen | ITM2C fusion protein Ag4409 相同性解析による交差性が予測される生物種 |
Full Name | integral membrane protein 2C |
Calculated molecular weight | 230aa,26 kDa; 267aa,30 kDa |
Observed molecular weight | 35 kDa |
GenBank accession number | BC025742 |
Gene symbol | ITM2C |
Gene ID (NCBI) | 81618 |
RRID | AB_2883421 |
Conjugate | CoraLite®594 Fluorescent Dye |
Excitation/Emission maxima wavelengths | 588 nm / 604 nm |
Form | Liquid |
Purification Method | Protein A purification |
Storage Buffer | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
Storage Conditions | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
The Integral membrane protein 2C (ITM2C) is a type II integral transmembrane protein belonging to a family composed of at least two other members, ITM2A and ITM2B. ITM2C, often called transmembrane protein BRI3, is highly expressed in brain tissue. Yeast two-hybrid screen system revealed that BRI3 could interact with beta-secretase beta-amyloid protein converting enzyme (BACE)1 and the microtubule-destabilizing protein SCG10 (STMN2). It may play a role in TNF-induced cell death and neuronal differentiation. BRI3 was found to inhibit the various processing of amyloid precursor protein (APP) by blocking the access of alpha- and beta-secretases to APP, competitive inhibition of APP processing by BRI3 may provide a new approach to Alzheimer disease (AD) therapy and prevention.
Protocols
Product Specific Protocols | |
---|---|
IF protocol for CL594 ITM2C antibody CL594-60095 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |